ADx NeuroSciences and Alamar Biosciences Announce Partnership to Provide Customized Blood-Based Biomarker Assay Solutions to Accelerate Biopharma Clinical Development

Gent, Belgium & Fremont, Calif., United States:   ADx NeuroSciences, a wholly owned subsidiary of Fujirebio and a leader in neurodegenerative

READ MORE